PROVE-IT
2004
Pravastatin or Atorvastatin Evaluation and Infection Therapy — Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22)
In 4,162 patients after acute coronary syndrome, intensive atorvastatin 80 mg reduced death or major cardiovascular events compared with moderate pravastatin 40 mg (16% relative reduction, P=0.005).
Result
- Absolute difference
- 3.9 points
- NNT
- 26
relative reduction1695% CI 5-26 · P = 0.005
Absolute difference and NNT are derived from the event rates.
Also reported: Median achieved LDL-C 62 vs 95 mg/dL.
- Subtopic
- Statins
- Design
- Double-blind, double-dummy, randomised active-comparator trial
- Relevance
- Important: one of several pillars.
- Source
- Cannon CP, et al. N Engl J Med. 2004;350(15):1495-1504.doi 10.1056/NEJMoa040583
Discussion & critique
Design confounds statin intensity with two different agents/doses so benefit cannot be attributed to LDL lowering alone. Established the 'lower is better' paradigm and high-intensity statin therapy as standard after acute coronary syndrome.